JAMES EDWARD BUTRYNSKI M.D. NPI 1427134287

NPI Information

  • NPI: 1427134287
  • Provider Name: JAMES EDWARD BUTRYNSKI, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 520 COUNTRY CLUB PKWY
    EUGENE, OR
    ZIP 97401
  • Phone: (541) 683-5001

Map and Directions

Get Directions

NPI Details

James Edward Butrynski, M.D. is a hematology and oncology internal medicine in Eugene, OR with 33 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. James Edward Butrynski, M.D. NPI is 1427134287. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1993

The provider's business location address is:

520 COUNTRY CLUB PKWY
EUGENE, OR
ZIP 97401-043
Phone: (541) 683-5001
Fax: (541) 683-1422

The NPI 1427134287 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Unclassified drugs (HCPCS:J3490)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 10/27/2006 and was last updated on 5/4/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyMD180586OREGONYes
2207RH0003XInternal MedicineHematology & Oncology230942MASSACHUSETTSNo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.